Esperion Therapeutics
ESPR
#6169
Rank
C$1.22 B
Marketcap
C$5.15
Share price
-1.58%
Change (1 day)
10.03%
Change (1 year)

Esperion Therapeutics (ESPR) - Total assets

Total assets on the balance sheet as of September 2025 : C$0.50 Billion

According to Esperion Therapeutics's latest financial reports the company's total assets are C$0.50 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Esperion Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31C$0.49 B80.75%
2023-12-31C$0.27 B-18.87%
2022-12-31C$0.33 B-30.82%
2021-12-31C$0.48 B7.97%
2020-12-31C$0.45 B60.82%
2019-12-31C$0.28 B43.33%
2018-12-31C$0.19 B-44.06%
2017-12-31C$0.34 B6%
2016-12-31C$0.32 B-19.63%
2015-12-31C$0.41 B146.6%
2014-12-31C$0.16 B99.5%
2013-12-31C$83.34 M1046.17%
2012-12-31C$7.27 M227.95%
2011-12-31C$2.21 M
2002-12-31C$81.19 M-34.94%
2001-12-31C$0.12 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Ultragenyx Pharmaceutical
RARE
C$1.64 B 227.03%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$10.51 B 1,991.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$288.36 B 57,240.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$55.49 B 10,934.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$1.20 B 138.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C$0.28 B-43.43%๐Ÿ‡บ๐Ÿ‡ธ USA